2025 Regular Session • West Virginia Legislature
HB3092: Relating to financial assistance available for a prescription drug
Legislative Summary
The purpose of this bill is to ensure financial or product assistance are available for a prescription drug.
Demographic Impact
Overall analysis of equity impact
60% Positive
Low ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
3/3/2025
Filed for introduction
House of Delegates
3/3/2025
To Finance
House of Delegates
3/3/2025
Introduced in House
House of Delegates
3/3/2025
To House Finance
House of Delegates
3/25/2025
By substitute, do pass
House of Delegates
3/26/2025
On 1st reading, Special Calendar
House of Delegates
3/26/2025
Read 1st time
House of Delegates
3/27/2025
On 2nd reading, Special Calendar
House of Delegates
3/27/2025
Read 2nd time
House of Delegates
3/28/2025
On 3rd reading, Special Calendar
House of Delegates
3/28/2025
Read 3rd time
House of Delegates
3/28/2025
Passed House (Roll No. 243)
House of Delegates
3/28/2025
Communicated to Senate
House of Delegates
3/31/2025
Introduced in Senate
Senate
3/31/2025
To Health and Human Resources
Senate
3/31/2025
To Health and Human Resources
Senate
Roll Call Votes
Passed House (Roll No. 243)
3/28/2025
80
Yea
3
Nay
0
Not Voting
17
Absent
Result: PASSED
Status Information
Current Status
Engrossed(3/28/2025)
Chamber
Senate
Committee
Health and Human Resources(Senate)
Sponsors
Republican: 1
Primary Sponsor
Matthew Rohrbach
Republican